Singapore markets open in 48 minutes
  • Straits Times Index

    3,204.57
    +2.71 (+0.08%)
     
  • S&P 500

    4,574.79
    +8.31 (+0.18%)
     
  • Dow

    35,756.88
    +15.73 (+0.04%)
     
  • Nasdaq

    15,235.71
    +9.01 (+0.06%)
     
  • BTC-USD

    60,467.81
    -2,377.74 (-3.78%)
     
  • CMC Crypto 200

    1,463.51
    -41.64 (-2.77%)
     
  • FTSE 100

    7,277.62
    +54.80 (+0.76%)
     
  • Gold

    1,794.30
    +0.90 (+0.05%)
     
  • Crude Oil

    84.28
    -0.37 (-0.44%)
     
  • 10-Yr Bond

    1.6190
    -0.0160 (-0.98%)
     
  • Nikkei

    29,106.01
    0.00 (0.00%)
     
  • Hang Seng

    26,038.27
    -93.76 (-0.36%)
     
  • FTSE Bursa Malaysia

    1,584.20
    -3.74 (-0.24%)
     
  • Jakarta Composite Index

    6,656.94
    +31.24 (+0.47%)
     
  • PSE Index

    7,252.10
    +40.56 (+0.56%)
     

$73 Billion Nasal Drug Delivery Technology Market - Global Outlook to 2027 - ResearchAndMarkets.com

·3-min read

DUBLIN, October 14, 2021--(BUSINESS WIRE)--The "Nasal Drug Delivery Technology - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Global Nasal Drug Delivery Technology Market to Reach $73.3 Billion by 2027

Amid the COVID-19 crisis, the global market for Nasal Drug Delivery Technology estimated at US$51.6 Billion in the year 2020, is projected to reach a revised size of US$73.3 Billion by 2027, growing at a CAGR of 5.1% over the analysis period 2020-2027.

Nasal Sprays, one of the segments analyzed in the report, is projected to record a 6.2% CAGR and reach US$40 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Drops & Liquids segment is readjusted to a revised 4.4% CAGR for the next 7-year period.

The U.S. Market is Estimated at $15.2 Billion, While China is Forecast to Grow at 4.8% CAGR

The Nasal Drug Delivery Technology market in the U.S. is estimated at US$15.2 Billion in the year 2020. China, the world`s second-largest economy, is forecast to reach a projected market size of US$12.9 Billion by the year 2027 trailing a CAGR of 4.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5% and 4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.1% CAGR.

Other Dosage Forms Segment to Record 2.5% CAGR

In the global Other Dosage Forms segment, USA, Canada, Japan, China and Europe will drive the 2.5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$4.2 Billion in the year 2020 will reach a projected size of US$5 Billion by the close of the analysis period. China will remain among the fastest-growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$8.4 Billion by the year 2027.

Select Competitors (Total 47 Featured):

  • 3M Company

  • Aegis Therapeutics LLC

  • Aptargroup, Inc.

  • AstraZeneca PLC

  • GlaxoSmithKline PLC

  • Johnson & Johnson

  • Merck & Co., Inc.

  • Novartis International AG

  • Pfizer, Inc.

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION

  • Total Companies Profiled: 47

For more information about this report visit https://www.researchandmarkets.com/r/gqf9tm

View source version on businesswire.com: https://www.businesswire.com/news/home/20211014005585/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting